Michael P Mariani, PhD

I think the AI ecosystem will merge with the human ecosystem, after all AI was born from human intelligence(s) so I would expect our respective intelligence taxonomies are similar and thus Integratable, and that integration would be favorable given that b…lnkd.in/etrGWXYx

I’m happy to share that I’m starting a new position as Technical Supervisor at Absolute Genomics! lnkd.in/eMJi7_eU

Hi everyone - I am looking for a new role and would appreciate your support. Thank you in advance for any connections, advice, or opportunities you can offer. #OpenToWork lnkd.in/dTNcAFRy

mitsha.re/GsSQ50JPxMl @WhitfieldLab

Ze Zhang , like we talked about 😄 . lnkd.in/gtynAv7A

Lucas A Salas @ZeZhang0223 @SeqWithSteve #JenniferChen lnkd.in/gUq2bt3d

Paper alert @MiKMERiani publication MethylMasteR a customizable Methylation-Based Copy Number Variation. We wrapped several of the current pipelines for methylation-based CNV analysis. If you want to learn more the #openaccess paper is available here doi.org/10.3389/fbinf.…

Docker version of the software is available on Zenodo dx.doi.org/10.5281/zenodo… and GitHub. Group science with #JenniferChen @ZeZhang0223 @SeqWithSteve Feedback and troubleshooting are always welcome. @GeiselMed @QBSdartmouth @DartmouthNeuro

Hot off the press from the Salas lab. Congratulations @lsalas_epigenet and @ZeZhang0223 ! #DNAmethylation #SalasLab #CancerResearch

End of evolution: transforming medicine through AI to reverse human disease ted.com/talks/manolis_… @TEDTalks #TEDxMIT #Genomics @MIT @BroadInstitute @MIT_CSAIL @MITEECS @HarvardMed #pharma

A new @ScienceMagazine study reports that the risk of #MultipleSclerosis (MS) increased 32-fold after infection with #EpsteinBarr virus (EBV), and suggest EBV as the leading cause of MS. science.org/doi/10.1126/sc…

Just in @NEJM 👉HIF-2α inhibitor Belzutifan 120 mg QD PO leads to 49% ORR in pts with #kidneycancer associated with VHL disease. Open acccess👉bit.ly/3l8Y48J Congrats @EJonasch & team Very proud to see @maughanonc @huntsmancancer @Huntsman_GU 👇 @OncoAlert @NeliMUlrich

adjuvant pembrolizumab is FDA approved in int/high RCC (post nephrectomy) with significant DFS data. While OS is not yet mature it is trending in the right direction making this approach attractive. ESMO guidelines are also supportive (level 1C). fda.gov/drugs/resource…

Just in @KCA_Journal 👉A rapid review+ meta-analysis of 1st line ImmunoRx combinations in metastatic #kidneycancer by @JShpil26 @BIDMCUrology #DavidMcDermott Will be very helpful in discussion with a newly diagnosed patient👇 bit.ly/3qRQenV @OncoAlert @urotoday

#WorldDiabetesDay #diabetes twitter.com/i/spaces/1yNGa…

Representing Dartmouth College at IKCS2021 in Austin! @ZeZhang0223 @lsalas_epigenet @saeedhp